Navigation Links
SyntheMed Receives CE Mark Approval for REPEL-GYN™
Date:5/24/2010

ISELIN, N.J., May 24 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, today announced that REPEL-GYN™, the company's bioresorbable adhesion barrier film for the reduction of adhesions following gynecologic surgery, has received CE Mark approval in the European Union (EU).  CE Mark approval signifies that REPEL-GYN has met the essential requirements of the European Union Medical Devices Directive and enables the company to begin marketing the product to reduce the incidence, severity and extent of post-operative adhesion formation in patients undergoing gynecologic surgery.  

The formation of adhesions (scar tissue) between organs in the pelvic cavity is a frequent, undesirable result of gynecologic surgery.  Pelvic adhesions can cause the patient to endure chronic pain, small bowel obstruction and infertility.  The presence of adhesions is also a complicating factor in repeat caesarian sections.  There are an estimated 2 million gynecologic procedures performed annually in the EU and other international markets in which the patients are at risk of developing adhesion-related complications.

Robert P. Hickey, President and CEO, SyntheMed, Inc., stated, "We are very pleased to have received regulatory approval to expand the use of our proprietary bioresorbable polymer film in the EU markets.  REPEL-GYN is similar to REPEL-CV® Adhesion Barrier which is currently marketed internationally for use in all cardiac surgical procedures and in pediatric cardiac surgery in the United States.  We are currently evaluating our options on the marketing of REPEL-GYN throughout the EU either through a corporate partn
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM)
2. SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM)
3. SyntheMed Receives US Patent on Novel Polymer Technology
4. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
5. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
6. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
7. SyntheMed Announces FDA Clearance of SinusShield(TM)
8. SyntheMed Announces New Management Appointments
9. SyntheMed Completes $4.0 Million Equity Placement
10. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
11. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... The Gerresheimer,Group today opened a new plant ... production facility constructed in Danyang (Jiangsu Province),covers ... and cartridges for injection systems it serves ... a local and international level. Dr. Axel ...
... MISSISSAUGA, ON, May 28 /PRNewswire-FirstCall/ - YM BioSciences ... an oncology company that identifies, develops and commercializes ... a poster presentation will report results from a ... with head and neck cancer conducted by Biocon ...
... patient was supported with the,Berlin Heart EXCOR(R) Pediatric Ventricular ... first implantation of the device in 1990. The,patient, an ... in Chicago and has been successfully transplanted in the ... diagnosed a few weeks after birth with left,ventricular non ...
Cached Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:4/15/2014)... could know as early as 2020 how high sea levels ... of researchers including Florida International University scientist Rene Price. , ... Florida Coastal Everglades Long-Term Ecological Research (LTER) site, one of ... to deserts, mountains to salt marshes around the world. , ...
(Date:4/15/2014)... If an insect drew a line as it chased ... mess. But there,s method to that mess, says Jane Wang, ... tries to find simple physical explanations for complex, hardwired animal ... the tiger beetle, known for its speed and agility, does ...
(Date:4/15/2014)... The American Association of Anatomists (AAA) is honored to announce ... during the Closing Awards Ceremony being held at the San ... during AAA,s 2014 Annual Meeting at Experimental Biology (EB). ... Henry Gray/Elsevier Distinguished Educator Medal: Jeffrey Laitman, PhD, of ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Photo: Tiger beetle's chase highlights mechanical law 2American Association of Anatomists 2014 award winners 2
... to differentiate between sweet and bitter tastes may reside in ... The study explains the discovery of a chemical messenger called ... long known that NPY is active in the brain and ... is also active in taste bud cells. , That finding ...
... help improve the effectiveness of chemotherapy at treating head ... Comprehensive Cancer Center have found. , The findings, which ... Cancer Therapeutics, could lead to a treatment that provides ... patients preserve vital organs involved in speech and swallowing. ...
... fast switch that uses water droplets to create adhesive bonds ... in palm beetles. , The new beetle-inspired switch, designed ... scale of a micron -- a millionth of a meter. ... like powerful adhesive bonding. Like the transistor, whose varied uses ...
Cached Biology News:Bitter or sweet? The same taste bud can tell the difference 2Bitter or sweet? The same taste bud can tell the difference 3Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3Beetle-inspired switch uses water for bonding 2
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... Goat polyclonal to Cholesterol Oxidase Immunogen ... Specificity Cross-reacts with bacteria. Not yet ... Cholesterol oxidases exist as both type ... implicated in bacterial pathogenesis. In addition, they ...
Phospho-PERK (Thr980) Antibody...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
Biology Products: